It’s About Time: US FDA’s Review Speed For Novel Approvals In 2025

 
• By Bridget Silverman and Nancy Pham
  
perspectives 2026
Accelerated Time
The FDA met nearly all of its PDUFA goals for novel products in 2025. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Pink Sheet